Clinical trials
Completed Lung Diseases, Interstitial trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2010 | 1 |
| 2013 | 2 |
| 2016 | 1 |
| 2017 | 5 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 6 |
| Hoffmann-La Roche | 2 |
| University of Manitoba | 2 |
| Actelion | 1 |
| Bristol-Myers Squibb | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Dr. Denis O'Donnell | 1 |
| Genentech, Inc. | 1 |
| Kyntra Bio | 1 |
| Laval University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 21 |
| Idiopathic Pulmonary Fibrosis | 5 |
| Pulmonary Fibrosis | 3 |
| Dyspnea | 2 |
| Idiopathic Interstitial Pneumonias | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Connective Tissue Diseases | 1 |
| Disease Progression | 1 |
| Mobility Limitation | 1 |
| Scleroderma, Diffuse | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.